ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,688, issued on April 15, was assigned to SPRINGWORKS THERAPEUTICS INC. (Stamford, Conn.).
"Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof" was invented by Kristin Patterson (Stamford, Conn.), Jiping Liu (Stamford, Conn.), Ricky Wayne Couch (Durham, N.C.), Peter Gregory Varlashkin (Durham, N.C.), Mai Li (Greenville, S.C.) and Yonghong Gan (Simpsonville, S.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to: a) crystalline forms of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide; b) pharmaceutical...